Cardiac microphysiological devices with flexible thin-film sensors for higher-throughput drug screening.
暂无分享,去创建一个
Ian Perkins | Johan U. Lind | Hongyan Yuan | Johan U Lind | Moran Yadid | Blakely B O'Connor | Feyisayo Eweje | Christophe O Chantre | Matthew A Hemphill | Patrick H Campbell | Joost J Vlassak | Kevin K Parker | M. Hemphill | J. Vlassak | K. Parker | Christophe O. Chantre | Patrick H. Campbell | Hongyan Yuan | Moran Yadid | Blakely B. O’Connor | Feyisayo Eweje | Ian Perkins
[1] R. W. Hansen,et al. Journal of Health Economics , 2016 .
[2] B. Duling,et al. TNF-α increases entry of macromolecules into luminal endothelial cell glycocalyx , 2000 .
[3] Kumaraswamy Nanthakumar,et al. Design and formulation of functional pluripotent stem cell-derived cardiac microtissues , 2013, Proceedings of the National Academy of Sciences.
[4] Megan L. McCain,et al. Coupling primary and stem cell – derived cardiomyocytes in an in vitro model of cardiac cell therapy , 2022 .
[5] Kevin Kit Parker,et al. Structural Phenotyping of Stem Cell-Derived Cardiomyocytes , 2015, Stem cell reports.
[6] G. Breithardt,et al. Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin. , 1998, Journal of cardiovascular pharmacology.
[7] Josue A. Goss,et al. Microfluidic heart on a chip for higher throughput pharmacological studies. , 2013, Lab on a chip.
[8] Ivan Rusyn,et al. Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity. , 2013, Toxicology and applied pharmacology.
[9] M. Diaz,et al. Effects of mefloquine on cardiac contractility and electrical activity in vivo, in isolated cardiac preparations, and in single ventricular myocytes , 2000, British journal of pharmacology.
[10] S. Wagner,et al. Controlling the morphology of gold films on poly(dimethylsiloxane). , 2010, ACS applied materials & interfaces.
[11] D. Brutsaert,et al. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. , 2003, Physiological reviews.
[12] Eva Wagner,et al. Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation. , 2015, Biomaterials.
[13] M. Simons,et al. Cell Communications in the Heart , 2010, Circulation.
[14] Kevin Kit Parker,et al. Micromolded gelatin hydrogels for extended culture of engineered cardiac tissues. , 2014, Biomaterials.
[15] G. Buckberg,et al. Ventricular structure-function relations in health and disease: Part I. The normal heart. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[16] S. Matalon,et al. Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability. , 1989, The American journal of physiology.
[17] Stéphanie P. Lacour,et al. Extended cyclic uniaxial loading of stretchable gold thin-films on elastomeric substrates , 2009 .
[18] D. Beebe,et al. PDMS absorption of small molecules and consequences in microfluidic applications. , 2006, Lab on a chip.
[19] Sung-Jin Park,et al. Instrumented cardiac microphysiological devices via multi-material 3D printing , 2016, Nature materials.
[20] M. Radisic,et al. Biodegradable scaffold with built-in vasculature for organ-on-a-chip engineering and direct surgical anastomosis , 2016, Nature materials.
[21] Kevin E. Healy,et al. Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses , 2016, Scientific Reports.
[22] Nenad Bursac,et al. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. , 2013, Biomaterials.
[23] Pal Pacher,et al. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? , 2004, Current pharmaceutical design.
[24] Megan L. McCain,et al. Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. , 2011, Lab on a chip.
[25] J. Coleman,et al. Sensitive electromechanical sensors using viscoelastic graphene-polymer nanocomposites , 2016, Science.
[26] Francisco Torrent-Guasp,et al. The helical ventricular myocardial band: global, three-dimensional, functional architecture of the ventricular myocardium. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[27] P. Nava,et al. Critical Role of Tight Junctions in Drug Delivery across Epithelial and Endothelial Cell Layers , 2005, The Journal of Membrane Biology.
[28] H L Greene,et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.
[29] Divya Rajamohan,et al. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation , 2011, European heart journal.
[30] M. Böhm,et al. Negative Inotropic Properties of Isradipine, Nifedipine, Diltiazem, and Verapamil in Diseased Human Myocardial Tissue , 1990, Journal of cardiovascular pharmacology.
[31] Thomas Boudou,et al. A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. , 2012, Tissue engineering. Part A.
[32] L. Miller. Cardiovascular Toxicities of Immunosuppressive Agents , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[33] Lisa J. McQuay,et al. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case‐control study , 2010, Pharmacoepidemiology and drug safety.
[34] W. Zimmermann,et al. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. , 2000, Biotechnology and bioengineering.
[35] U. Borchard,et al. Effect of Flecainide on Action Potentials and Alternating Current‐Induced Arrhythmias in Mammalian Myocardium , 1982, Journal of cardiovascular pharmacology.
[36] Gang Wang,et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014 .
[37] Marco F. Ramoni,et al. Clinical forecasting in drug development , 2007, Nature Reviews Drug Discovery.
[38] Mark D. Huffman,et al. Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.
[39] Luke P. Lee,et al. Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications , 2015, Scientific Reports.
[40] P Smith,et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.
[41] L. Jordaens,et al. Atrial flutter with 1: 1 conduction after administration of the antimalarial drug mefloquine , 1996, Clinical cardiology.
[42] Donald E Ingber,et al. Measuring direct current trans-epithelial electrical resistance in organ-on-a-chip microsystems. , 2015, Lab on a chip.
[43] Sigurd Wagner,et al. Mechanisms of reversible stretchability of thin metal films on elastomeric substrates , 2006 .
[44] P. Hunter,et al. Laminar structure of the heart: ventricular myocyte arrangement and connective tissue architecture in the dog. , 1995, The American journal of physiology.
[45] S. Hohnloser. Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management. , 1997, The American journal of cardiology.
[46] E. Seidman,et al. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients , 1995, The Lancet.
[47] G. Whitesides,et al. Muscular Thin Films for Building Actuators and Powering Devices , 2007, Science.
[48] Jean-Pierre Valentin,et al. Safety and secondary pharmacology: successes, threats, challenges and opportunities. , 2008, Journal of pharmacological and toxicological methods.
[49] C. January,et al. Block of HERG Potassium Channels by the Antihistamine Astemizole and its Metabolites Desmethylastemizole and Norastemizole , 1999, Journal of cardiovascular electrophysiology.
[50] M. Endoh. Force-frequency relationship in intact mammalian ventricular myocardium: physiological and pathophysiological relevance. , 2004, European journal of pharmacology.